P42 | Efficacy and safety of roxadustat in patients with non-dialysis-dependent chronic kidney disease with or without inflammation: pooled analysis of four phase 3 studies: G. Choukroun1, A. Harkavyi2, V. Santos3, A. Jiletcovici3, L. Del Vecchio4 | 1CHU Amiens Picardie and Jules Verne University, Amiens, France, 2Astellas Pharma Europe, Addlestone, UK, 3Astellas Pharma, Inc., Northbrook, USA, 4Sant’Anna Hospital, Como, Italy. Ital J Med [Internet]. 2025 Aug. 26 [cited 2025 Sep. 2];19(1(s1). Available from: https://www.italjmed.org/ijm/article/view/2234